Cencora SEC filings, summarized
We read every Cencora 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track COR in your inbox
Add Cencora to your watchlist — free, every morning.
Recent filings
Cencora filed Form 8‑K (Item 9.01) on Mar 23, 2026 — furnished Exhibit 99.1 (press release dated Mar 23,…
Cencora filed Form 8‑K (Item 9.01) on Mar 23, 2026 — furnished Exhibit 99.1 (press release dated Mar 23, 2026). Investors should review the PR for material…
Cencora ($COR) signed a definitive agreement (Mar 21, 2026; announced Mar 23, 2026) to acquire EyeSouth…
Cencora ($COR) signed a definitive agreement (Mar 21, 2026; announced Mar 23, 2026) to acquire EyeSouth Partners’ retina business. Press release furnished…
Cencora filed a Form 8‑K on Mar 17, 2026 — Exhibits: 99.1 (Press Release) and 104 (Inline XBRL cover page).
Cencora filed a Form 8‑K on Mar 17, 2026 — Exhibits: 99.1 (Press Release) and 104 (Inline XBRL cover page). Filing signed by Elizabeth S. Campbell, EVP &…
Cencora ($COR) on Mar 17, 2026 announced the retirement of Mr.
Cencora ($COR) on Mar 17, 2026 announced the retirement of Mr. Cleary and reaffirmed its previously issued adjusted diluted EPS guidance range for FY2026.…
Cencora ($COR) announced on Mar 17, 2026 that James F.
Cencora ($COR) announced on Mar 17, 2026 that James F. Cleary will retire as Executive VP & CFO effective June 30, 2026. His retirement was not due to any…
Cencora held its 2026 Annual Meeting on Mar 5, 2026.
Cencora held its 2026 Annual Meeting on Mar 5, 2026. All 11 director nominees were elected; "For" votes ranged ~163.3M–168.5M. Broker non‑votes: 9,738,568.…
Cencora ($COR) filed an 8‑K (Item 9.01) adding five supplemental indentures w/ U.S.
Cencora ($COR) filed an 8‑K (Item 9.01) adding five supplemental indentures w/ U.S. Bank Trust Co. for new senior notes: 3.95% due 2029, 4.25% due 2030,…
Filed 2/13/2026: Morgan, Lewis & Bockius LLP delivered a legal opinion on the validity of Cencora’s Notes…
Filed 2/13/2026: Morgan, Lewis & Bockius LLP delivered a legal opinion on the validity of Cencora’s Notes (attached as Exhibit 5.1) and consented to its…
Cencora ($COR) reports it closed the offering of its Notes, per Form 8‑K (Item 7.01).
Cencora ($COR) reports it closed the offering of its Notes, per Form 8‑K (Item 7.01). News release dated Feb 13, 2026 furnished as Exhibit 99.1. 📣 #Cencora…
Cencora ($COR) 8‑K filed 2026‑02‑13: Item 2.03 states that Item 1.01’s disclosures re: indentures and…
Cencora ($COR) 8‑K filed 2026‑02‑13: Item 2.03 states that Item 1.01’s disclosures re: indentures and notes are incorporated by reference as the creation of…
BREAKING: Cencora completes $3.0B sale of senior notes across five tranches (2029,2030,2033,2036,2056)…
BREAKING: Cencora completes $3.0B sale of senior notes across five tranches (2029,2030,2033,2036,2056) 🚨💵 Confirmed — $COR issued $3.0B of unsecured,…
Cencora filed an Underwriting Agreement dated Feb 10, 2026 with underwriters led by Citigroup, J.P.
Cencora filed an Underwriting Agreement dated Feb 10, 2026 with underwriters led by Citigroup, J.P. Morgan, BofA Securities & Wells Fargo (additional…
Cencora ($COR) entered an Underwriting Agreement on Feb 10, 2026 with Citigroup, J.P.
Cencora ($COR) entered an Underwriting Agreement on Feb 10, 2026 with Citigroup, J.P. Morgan, BofA & Wells Fargo to sell senior unsecured notes; expected…
Feb 10, 2026 — Cencora ($COR) priced $3.0B of senior notes in an underwritten registered offering: $500M…
Feb 10, 2026 — Cencora ($COR) priced $3.0B of senior notes in an underwritten registered offering: $500M 3.950% due 2029; $500M 4.250% due 2030; $500M…
Cencora ($COR) filed an 8‑K on Feb 10, 2026 revising its Form 10‑K for FY ended Sept 30, 2025 to update…
Cencora ($COR) filed an 8‑K on Feb 10, 2026 revising its Form 10‑K for FY ended Sept 30, 2025 to update previously reported segment results to conform to a…
Cencora ($COR) updates segment reporting effective FY2026 Q1 (period ended Dec 31, 2025).
Cencora ($COR) updates segment reporting effective FY2026 Q1 (period ended Dec 31, 2025). New structure: U.S. Healthcare Solutions; International Healthcare…
Cencora ($COR) filed a Form 8-K (Item 9.01) on Feb 4, 2026 — exhibits: News Release (Ex.
Cencora ($COR) filed a Form 8-K (Item 9.01) on Feb 4, 2026 — exhibits: News Release (Ex. 99.1) and Cover Page iXBRL (Ex. 104). Investors should review the…
Feb 2, 2026: Cencora ($COR) acquired the majority of OneOncology for ~ $4.6B cash; affiliated practices…
Feb 2, 2026: Cencora ($COR) acquired the majority of OneOncology for ~ $4.6B cash; affiliated practices and management retain a minority interest. Deal…
Cencora ($COR) issued an earnings news release on Feb 4, 2026 for the fiscal quarter ended Dec 31, 2025;…
Cencora ($COR) issued an earnings news release on Feb 4, 2026 for the fiscal quarter ended Dec 31, 2025; the release is attached to the 8‑K as Exhibit 99.1.…
Cencora ($COR) filed Form 8‑K on Jan 22, 2026 — Exhibits: 99.1 Press Release (dated Jan 22, 2026) and 104…
Cencora ($COR) filed Form 8‑K on Jan 22, 2026 — Exhibits: 99.1 Press Release (dated Jan 22, 2026) and 104 Cover Page Interactive XBRL. See Exhibit 99.1 for…